Endothelial progenitor cells in the pathogenesis of idiopathic pulmonary fibrosis: an evolving concept.

<h4>Background</h4>Idiopathic pulmonary fibrosis (IPF) has been associated with abnormal vascular remodeling. Bone marrow derived endothelial progenitor cells (EPCs) are considered to possess lung tissue repair and vascular remodeling properties.<h4>Objectives</h4>The study a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Foteini Malli, Angela Koutsokera, Efrosini Paraskeva, Epaminondas Zakynthinos, Maria Papagianni, Dimosthenes Makris, Irene Tsilioni, Paschalis Adam Molyvdas, Konstantinos I Gourgoulianis, Zoe Daniil
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f1e3224571e94dc0b73c6a04a6632892
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f1e3224571e94dc0b73c6a04a6632892
record_format dspace
spelling oai:doaj.org-article:f1e3224571e94dc0b73c6a04a66328922021-11-18T08:01:38ZEndothelial progenitor cells in the pathogenesis of idiopathic pulmonary fibrosis: an evolving concept.1932-620310.1371/journal.pone.0053658https://doaj.org/article/f1e3224571e94dc0b73c6a04a66328922013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23341966/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Idiopathic pulmonary fibrosis (IPF) has been associated with abnormal vascular remodeling. Bone marrow derived endothelial progenitor cells (EPCs) are considered to possess lung tissue repair and vascular remodeling properties.<h4>Objectives</h4>The study aimed to assess early EPCs levels and EPCs endogenous vascular endothelial growth factor (VEGF) expression in IPF. In order to examine alterations in the mobilization of EPCs from the bone marrow we measured plasma VEGF.<h4>Main results</h4>Twenty-three patients with IPF and fifteen healthy subjects were included. The number of early EPCs colonies was markedly reduced in IPF patients vs controls (6.00±6.49 vs 49.68±16.73, respectively, p<0.001). EPCs were further decreased in patients presenting systolic pulmonary arterial pressure (sPAP)≥35 mmHg. The number of colonies per well correlated negatively with P((A-a))O(2) (r =  -0.750, p<0.001). Additionally, VEGF mRNA levels were significantly increased in IPF patients. There were no differences observed in VEGF plasma levels in IPF patients when compared to controls.<h4>Conclusions</h4>The current data suggest that inadequate levels of early EPCs may potentially contribute to suppressed repair and recovery of the damaged pulmonary endothelium and thereby may drive the sequence of events in profibrogenic direction. Increased VEGFmRNA levels in the clinical context of IPF may represent a compensatory mechanism to overcome reduced EPCs levels.Foteini MalliAngela KoutsokeraEfrosini ParaskevaEpaminondas ZakynthinosMaria PapagianniDimosthenes MakrisIrene TsilioniPaschalis Adam MolyvdasKonstantinos I GourgoulianisZoe DaniilPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 1, p e53658 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Foteini Malli
Angela Koutsokera
Efrosini Paraskeva
Epaminondas Zakynthinos
Maria Papagianni
Dimosthenes Makris
Irene Tsilioni
Paschalis Adam Molyvdas
Konstantinos I Gourgoulianis
Zoe Daniil
Endothelial progenitor cells in the pathogenesis of idiopathic pulmonary fibrosis: an evolving concept.
description <h4>Background</h4>Idiopathic pulmonary fibrosis (IPF) has been associated with abnormal vascular remodeling. Bone marrow derived endothelial progenitor cells (EPCs) are considered to possess lung tissue repair and vascular remodeling properties.<h4>Objectives</h4>The study aimed to assess early EPCs levels and EPCs endogenous vascular endothelial growth factor (VEGF) expression in IPF. In order to examine alterations in the mobilization of EPCs from the bone marrow we measured plasma VEGF.<h4>Main results</h4>Twenty-three patients with IPF and fifteen healthy subjects were included. The number of early EPCs colonies was markedly reduced in IPF patients vs controls (6.00±6.49 vs 49.68±16.73, respectively, p<0.001). EPCs were further decreased in patients presenting systolic pulmonary arterial pressure (sPAP)≥35 mmHg. The number of colonies per well correlated negatively with P((A-a))O(2) (r =  -0.750, p<0.001). Additionally, VEGF mRNA levels were significantly increased in IPF patients. There were no differences observed in VEGF plasma levels in IPF patients when compared to controls.<h4>Conclusions</h4>The current data suggest that inadequate levels of early EPCs may potentially contribute to suppressed repair and recovery of the damaged pulmonary endothelium and thereby may drive the sequence of events in profibrogenic direction. Increased VEGFmRNA levels in the clinical context of IPF may represent a compensatory mechanism to overcome reduced EPCs levels.
format article
author Foteini Malli
Angela Koutsokera
Efrosini Paraskeva
Epaminondas Zakynthinos
Maria Papagianni
Dimosthenes Makris
Irene Tsilioni
Paschalis Adam Molyvdas
Konstantinos I Gourgoulianis
Zoe Daniil
author_facet Foteini Malli
Angela Koutsokera
Efrosini Paraskeva
Epaminondas Zakynthinos
Maria Papagianni
Dimosthenes Makris
Irene Tsilioni
Paschalis Adam Molyvdas
Konstantinos I Gourgoulianis
Zoe Daniil
author_sort Foteini Malli
title Endothelial progenitor cells in the pathogenesis of idiopathic pulmonary fibrosis: an evolving concept.
title_short Endothelial progenitor cells in the pathogenesis of idiopathic pulmonary fibrosis: an evolving concept.
title_full Endothelial progenitor cells in the pathogenesis of idiopathic pulmonary fibrosis: an evolving concept.
title_fullStr Endothelial progenitor cells in the pathogenesis of idiopathic pulmonary fibrosis: an evolving concept.
title_full_unstemmed Endothelial progenitor cells in the pathogenesis of idiopathic pulmonary fibrosis: an evolving concept.
title_sort endothelial progenitor cells in the pathogenesis of idiopathic pulmonary fibrosis: an evolving concept.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/f1e3224571e94dc0b73c6a04a6632892
work_keys_str_mv AT foteinimalli endothelialprogenitorcellsinthepathogenesisofidiopathicpulmonaryfibrosisanevolvingconcept
AT angelakoutsokera endothelialprogenitorcellsinthepathogenesisofidiopathicpulmonaryfibrosisanevolvingconcept
AT efrosiniparaskeva endothelialprogenitorcellsinthepathogenesisofidiopathicpulmonaryfibrosisanevolvingconcept
AT epaminondaszakynthinos endothelialprogenitorcellsinthepathogenesisofidiopathicpulmonaryfibrosisanevolvingconcept
AT mariapapagianni endothelialprogenitorcellsinthepathogenesisofidiopathicpulmonaryfibrosisanevolvingconcept
AT dimosthenesmakris endothelialprogenitorcellsinthepathogenesisofidiopathicpulmonaryfibrosisanevolvingconcept
AT irenetsilioni endothelialprogenitorcellsinthepathogenesisofidiopathicpulmonaryfibrosisanevolvingconcept
AT paschalisadammolyvdas endothelialprogenitorcellsinthepathogenesisofidiopathicpulmonaryfibrosisanevolvingconcept
AT konstantinosigourgoulianis endothelialprogenitorcellsinthepathogenesisofidiopathicpulmonaryfibrosisanevolvingconcept
AT zoedaniil endothelialprogenitorcellsinthepathogenesisofidiopathicpulmonaryfibrosisanevolvingconcept
_version_ 1718422640773824512